---
title: "67 stocks received buy ratings from institutions today, with 21 stocks having an upside potential exceeding 20%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/226004195.md"
description: "Today, institutional research reports released 92 buy ratings, involving 67 stocks. Juhua Co., Ltd. received 6 buy ratings, with 21 out of 31 rating records showing an upside potential exceeding 20%. Shandong Pharmaceutical Glass has the highest upside potential, with a target price of 41.16 yuan, representing a 69.94% increase. Other stocks with relatively high upside potential include T&S and GLODON, at 50.07% and 49.38%, respectively. Today, there are 10 ratings marked as first-time attention, involving Changhong Technology, First Pharmaceutical, and others"
datetime: "2025-01-23T13:17:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/226004195.md)
  - [en](https://longbridge.com/en/news/226004195.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/226004195.md)
generator: "portal-rs"
---

# 67 stocks received buy ratings from institutions today, with 21 stocks having an upside potential exceeding 20%

According to statistics from Data Treasure, today a total of 92 buy ratings were released by institutions, involving 67 individual stocks. Juhua Co., Ltd. received the highest attention, with 6 buy ratings from institutions. Among the stocks that received buy ratings today, 31 ratings provided future target prices for the relevant stocks. A comparison of the published target prices with the latest closing prices shows that 21 stocks have an upside potential exceeding 20%. Shandong Pharmaceutical Glass has the highest upside potential, with Haitong Securities estimating the company's target price at 41.16 yuan on January 23, indicating an upside potential of 69.94%. Other stocks with high upside potential include T&S and GLODON, with upside potentials of 50.07% and 49.38%, respectively. In terms of changes in institutional ratings, among today's buy ratings, there were 10 records that were the first attention from institutions, involving Changhong Technology, First Pharmaceutical, and 8 other stocks

### Related Stocks

- [300570.CN](https://longbridge.com/en/quote/300570.CN.md)
- [002410.CN](https://longbridge.com/en/quote/002410.CN.md)
- [600529.CN](https://longbridge.com/en/quote/600529.CN.md)
- [300151.CN](https://longbridge.com/en/quote/300151.CN.md)
- [600833.CN](https://longbridge.com/en/quote/600833.CN.md)
- [600160.CN](https://longbridge.com/en/quote/600160.CN.md)

## Related News & Research

- [OpenAI's ad business shows blistering growth, hits $1 billion annualized revenue run rate](https://longbridge.com/en/news/297522913.md)
- [Security Risk Advisors Launches SCALR AI as a Free SOC AI Platform for Security Teams](https://longbridge.com/en/news/297523531.md)
- [Trump Signs Order to Create US Space Academy, Eyes Moon Landing Before End of Presidency](https://longbridge.com/en/news/297402922.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)
- [Earth Science Tech, Inc. Announces 2026 Annual Shareholder Meeting Results | ETST Stock News](https://longbridge.com/en/news/297687527.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**